Tango Therapeutics Inc (TNGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,125 | 3,038 | 1,111 | 530 | 192 |
| Depreciation Amortization | 2,656 | 9,542 | 6,783 | 4,253 | 2,074 |
| Income taxes - deferred | 111 | 183 | 75 | 14 | 6 |
| Accounts receivable | 452 | -5,883 | -826 | 25 | 190 |
| Accounts payable and accrued liabilities | 1,529 | 1,310 | 459 | 105 | 928 |
| Other Working Capital | -517 | -5,382 | -1,013 | -999 | -367 |
| Other Operating Activity | 486 | 13,880 | 6,946 | 3,614 | 506 |
| Operating Cash Flow | $5,842 | $16,688 | $13,535 | $7,542 | $3,529 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -273 | -1,820 | -1,333 | -750 | -426 |
| Net Acquisitions | -8,789 | -38,410 | -38,410 | -9,202 | -8,577 |
| Investing Cash Flow | $-9,062 | $-40,230 | $-39,743 | $-9,952 | $-9,003 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 778 | N/A | N/A | N/A |
| Debt Repayment | -307 | -9,676 | -2,986 | -2,751 | -1,544 |
| Common Stock Issued | 306 | 41,903 | 41,470 | 40,213 | 1,396 |
| Common Stock Repurchased | -3,235 | -2,700 | 0 | N/A | 0 |
| Other Financing Activity | 0 | 93 | 93 | 93 | 70 |
| Financing Cash Flow | $-3,236 | $30,398 | $38,577 | $37,555 | $-78 |
| Exchange Rate Effect | -201 | -52 | -40 | -110 | 11 |
| Beginning Cash Position | 50,211 | 43,407 | 43,407 | 43,407 | 43,407 |
| End Cash Position | 43,554 | 50,211 | 55,736 | 78,442 | 37,866 |
| Net Cash Flow | $-6,657 | $6,804 | $12,329 | $35,035 | $-5,541 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,842 | 16,688 | 13,535 | 7,542 | 3,529 |
| Capital Expenditure | -273 | -1,820 | -1,333 | -750 | -426 |
| Free Cash Flow | 5,569 | 14,868 | 12,202 | 6,792 | 3,103 |